Home/Filings/4/0001127602-10-016676
4//SEC Filing

SIMON ROBERT L 4

Accession 0001127602-10-016676

CIK 0000729922other

Filed

Jun 6, 8:00 PM ET

Accepted

Jun 7, 8:16 PM ET

Size

30.4 KB

Accession

0001127602-10-016676

Insider Transaction Report

Form 4
Period: 2010-06-03
SIMON ROBERT L
Exec. VP, Pharm. Dev. & Manf.
Transactions
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2010-06-03$57.50/sh23,600$1,357,0000 total
    Exercise: $30.74Exp: 2013-06-24Common Stock (23,600 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2010-06-03$57.50/sh17,200$989,0000 total
    Exercise: $67.63Exp: 2014-06-16Common Stock (17,200 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2010-06-03$57.50/sh15,000$862,5000 total
    Exercise: $29.77Exp: 2013-06-12Common Stock (15,000 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2010-06-03$57.50/sh22,000$1,265,0000 total
    Exercise: $47.29Exp: 2014-12-11Common Stock (22,000 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2010-06-03$57.50/sh60,000$3,450,0000 total
    Exercise: $33.62Exp: 2015-12-15Common Stock (60,000 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2010-06-03$57.50/sh24,000$1,380,0000 total
    Exercise: $35.40Exp: 2019-12-14Common Stock (24,000 underlying)
  • Tax Payment

    Common Stock

    2010-06-03$57.50/sh514$29,5551,016 total
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2010-06-03$57.50/sh21,850$1,256,3750 total
    Exercise: $38.01Exp: 2012-06-14Common Stock (21,850 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2010-06-03$57.50/sh11,250$646,8750 total
    Exercise: $37.74Exp: 2013-12-12Common Stock (11,250 underlying)
  • Disposition to Issuer

    Common Stock

    2010-06-03$57.50/sh20,105$1,156,03820,574 total
  • Disposition from Tender

    Common Stock

    2010-06-03$57.50/sh19,044$1,095,0301,530 total
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2010-06-03$57.50/sh44,000$2,530,0000 total
    Exercise: $45.01Exp: 2012-01-01Common Stock (44,000 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2010-06-03$57.50/sh2,300$132,2500 total
    Exercise: $21.55Exp: 2012-06-11Common Stock (2,300 underlying)
Footnotes (5)
  • [F1]Represents the number of unvested Restricted Stock Units that were canceled in exchange for a cash payment of $57.50 per unit in accordance with the Agreement and Plan of Merger, dated as of May 16, 2010, among OSI Pharmaceuticals, Inc., Astellas Pharma Inc., Astellas US Holding, Inc. and Ruby Acquisition, Inc.
  • [F2]Due to a clerical error, Column 5 of Table I of prior Form 4s filed for Mr. Simon overstated the number of shares of common stock beneficially owned by Mr. Simon by 74 shares. Accordingly, the reported number of securities beneficially owned by Mr. Simon following the reported transactions has been adjusted in this Form 4 to remove the 74 shares of common stock that were incorrectly included in his prior Form 4s. The total also includes 73 shares acquired under the OSI Employee Stock Purchase Plan on June 2, 2010.
  • [F3]Reflects the withholding of shares by the company to satisfy the tax liability upon the vesting of restricted stock.
  • [F4]These stock options were canceled in exchange for a cash payment in accordance with the Agreement and Plan of Merger, dated as of May 16, 2010, among OSI Pharmaceuticals, Inc., Astellas Pharma Inc., Astellas US Holding, Inc. and Ruby Acquisition, Inc. The cash payment made with respect to each stock option equals the product of (x) the number of shares issuable upon the exercise of such option multiplied by (y) the excess, if any, of $57.50 over the exercise price per share for such option.
  • [F5]These stock options were canceled in accordance with the Agreement and Plan of Merger, dated as of May 16, 2010, among OSI Pharmaceuticals, Inc., Astellas Pharma Inc., Astellas US Holding, Inc. and Ruby Acquisition, Inc. As the exercise price of the options was above $57.50, no cash payment was provided.

Issuer

OSI PHARMACEUTICALS INC

CIK 0000729922

Entity typeother

Related Parties

1
  • filerCIK 0001220050

Filing Metadata

Form type
4
Filed
Jun 6, 8:00 PM ET
Accepted
Jun 7, 8:16 PM ET
Size
30.4 KB